A toolbox from RNA design to delivery

A powerful toolbox of technologies, to fast track your RNA development from design to delivery

Our toolbox of technologies provides our partners with a comprehensive set of solutions to enable RNA adoption, starting from a simple antigen sequence. This end-to-end RNA solution supports molecular design, RNA production and formulation, as well as derisking studies conducted in vitro and in vivo.

Logo Ncode color

Advanced bioinformatics to enhance expression, stability, and manufacturability

Our platform goes beyond standard codon optimization, enabling seamless transition from antigen design to fully optimized RNA-based modalities. With our technology-driven approach, we help accelerate the path from concept to scalable mRNA production.

Computer ship with a DNA coming out to illustrate our bioinformatics expertise
Quantoom Ntensify mRNA production technologies
Logo Ntensify
  • For mRNA & saRNA
  • Construct agnostic
  • Scalable process

Our turnkey solutions provide scalable production capabilities to cover your needs, from µg-scale research quantities to kg-scale pandemic resilience. The Ntensify solution includes a construct agnostic process with a one-pot IVT and one-step purification; ready-to-use mixes of reagents and automated equipment with integrated production and purification.

Picture of a lipid to illustrate the RNA delivery chemistries or the RNA formulation chemistries.
Logo Ncapsulate QCX

Customizable FTO chemistries with demonstrated performances in mRNA & saRNA

A new class of lipids-like chemistries with customizable structures, tailored to meet unique therapeutic needs of our partners. Our lipid-like chemistry are free from third-party IP constraints, opening a new possibilities for RNA delivery in an IP-dense market.

Ensuring a smooth transition to RNA-based vaccines and therapeutics

Acknowledging the need of our partners to leverage our broad expertise in RNA bioprocessing, we offer tailor-made partnership solutions to guide them from RNA design, production, formulation and evaluation.

Swipe horizontally to explore →

Animal health
RNA
LLP
Sequence design & optimization
RNA/formulation preparation
In vitro testing
POC in target species
Early-phase development
Partners
sa/mRNA
QCX-002
Ncode
PPRV
CVIM The Pirbright Institute
saRNA
QCX-002
Ncode
Avian Influenza, HPAI
VaxThera
mRNA
QCX-002
Ncode
Feline cancer
Feline cancer
Undisclosed partner
mRNA
QCX-002
Ncode
Inf. disease
Undisclosed partner

Swipe horizontally to explore →

Cancer vaccines
RNA
LLP
Sequence design & optimization
RNA/formulation preparation
In vitro testing
Preclinical
Clinical
Partners
mRNA
QCX-002
Ncode
Melanoma (shared antigen)
Serum Institute of India
mRNA
QCX-002
Ncode
Melanoma (neoantigen)
Arizona State University
mRNA
QCX-002
Ncode
Colorectal (neoantigen)
Oxford Cancer
mRNA
QCX-002
Ncode
CAR-T
Undisclosed partner

Swipe horizontally to explore →

Prophylactic vaccines
RNA
LLP
Sequence design & optimization
RNA/formulation preparation
In vitro testing
Preclinical
Clinical
Partners
mRNA
REF LLP
Ncode
Rabies
Internal program
mRNA
REF LLP
Ncode
COVID-19 & Influenza
Horizon Europe
saRNA
QCX-002
Ncode
Influenza H5N1
Serum Institute of India
mRNA
REF LLP
Ncode
Malaria
European Vaccine Initiative